Aduro Biotech (ADRO) Posts Q1 Loss of $39.97/Share
Get Alerts ADRO Hot Sheet
Join SI Premium – FREE
Aduro Biotech (NASDAQ: ADRO) reported Q1 EPS of ($39.97), $39.89 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $9.6 million versus the consensus estimate of $9.24 million.
The company posted a loss of $26.34 per share in the same period last year.
For earnings history and earnings-related data on Aduro Biotech (ADRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Oilfield firm SLB's profit rises on international drilling demand
- Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!